FDA accepts Airway’s IND for AT-100 for bronchopulmonary dysplasia treatment in preterm infants

Bronchopulmonary dysplasia treatment : Airway Therapeutics said that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for developing ... Read More